NA
VCYT icon

Neuburgh Advisers’s Veracyte VCYT Stock Holding History

Neuburgh Advisers’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$359K Buy
+14,976
New +$398K 0.01% 546

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Neuburgh Advisers's VCYT Position: Q3 2019 in Review

Neuburgh Advisers opened a new position in Veracyte (VCYT) in Q3 2019: 14,976 shares worth $359K. The stake represents 0.01% of the portfolio and ranks #546 among its holdings.

187 funds tracked by Wall St. Rank hold VCYT as of Q3 2019.

  • Neuburgh Advisers held 14,976 shares of Veracyte worth $359K as of Q3 2019.
  • Veracyte was a new Neuburgh Advisers position in Q3 2019.
  • Veracyte made up 0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #546 holding.
  • 187 funds tracked by Wall St. Rank held Veracyte as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.